Anzeige
Mehr »
Login
Samstag, 11.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
100 % Anstieg in zwei Tagen: Das technische Signal, das Wall Streets Bären in Panik versetzt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
309 Leser
Artikel bewerten:
(1)

David Linke to become Global Head of Tax and Legal practice

Finanznachrichten News

SYDNEY, July 24, 2020 /PRNewswire/ -- KPMG International today announced that David Linke has been selected as the next Global Head of Tax & Legal services, effective 1 October 2020. He succeeds in this role Jane McCormick who has successfully led the Global Tax & Legal network since 2016.

David is currently the Asia Pacific Regional Leader for Tax, as well as the Head of Tax, Deals and Legal for KPMG Australia, serving on the International Tax Steering Group and on the KPMG regional board in the Asia Pacific. As a part of this new appointment, David will serve on the KPMG Global Management Team led by KPMG International Chairman, Bill Thomas.

"In his remarkable career, David has built a well-deserved reputation in market for taking a creative approach to complex business challenges, and helping clients to do the same," said Bill Thomas. "This is precisely the kind of leadership needed today, especially in the wake of Covid-19, and I am confident that David will be able to build successfully on the momentum gained for the practice under Jane McCormick's leadership in recent years."

"I am pleased to pass the torch to David, a valued leader whose relentless focus on and knowledge of the global tax landscape, as well as the new realities facing the profession, will yield meaningful results for our global network and member firm clients," said Jane McCormick.

Having first joined KPMG's Tax practice in 1993, David brings to the global role extensive experience working with multinational organizations around the world on a range of tax and legal matters, with deep expertise in structuring and cross-border mergers and acquisitions and a passion for technology and innovation within the tax department.

David has also been a strong advocate and proponent for KPMG's Global Legal Service offerings, having helped to build one of the most successful practices in the KPMG network through his time as Head of Global Tax & Legal for KPMG Australia. In addition, he has been a leader in tax technology, leading the build out of a significant and a market-leading tax technology and innovation team in Australia.

"I have always been proud to be a part of a network of more than 30,000 colleagues around the world who are passionate about what they do, and it is humbling and exciting to be preparing to lead that network globally," said David. "The tax and legal professions face significant challenges in the need to transform and evolve, especially in these testing times. For me, my role will be all about bringing people together with different points of view and empowering them to work together towards solutions for our clients, our profession and the communities we serve."

About KPMG International

KPMG is a global network of professional services firms providing Audit, Tax and Advisory services. We operate in 147 countries and territories and have more than 219,000 people working in member firms around the world. The independent member firms of the KPMG network are affiliated with KPMG International Cooperative ("KPMG International"), a Swiss entity. Each KPMG firm is a legally distinct and separate entity and describes itself as such.

Photo - https://mma.prnewswire.com/media/1219264/KPMG_International_David_Linke.jpg

© 2020 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.